Equities

Shandong Bailong Chuangyuan Bio-Tech Co Ltd

605016:SHH

Shandong Bailong Chuangyuan Bio-Tech Co Ltd

Actions
Consumer Staples Food Producers
  • Price (CNY)16.83
  • Today's Change-0.150 / -0.88%
  • Shares traded1.28m
  • 1 Year change-4.42%
  • Beta1.7525
Data delayed at least 15 minutes, as of Sep 13 2024 08:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CNYIncome statement in CNYView more

Year on year Shandong Bailong Chuangyuan Bio-Tech Co Ltd grew revenues 20.28% from 721.89m to 868.26m while net income improved 27.98% from 150.80m to 193.00m.
Gross margin31.91%
Net profit margin22.44%
Operating margin25.39%
Return on assets12.65%
Return on equity14.89%
Return on investment14.84%
More ▼

Cash flow in CNYView more

In 2023, cash reserves at Shandong Bailong Chuangyuan Bio-Tech Co Ltd fell by 63.20m. However, the company earned 194.63m from its operations for a Cash Flow Margin of 22.42%. In addition the company used 223.72m on investing activities and also paid 34.12m in financing cash flows.
Cash flow per share--
Price/Cash flow per share--
Book value per share4.85
Tangible book value per share4.80
More ▼

Balance sheet in CNYView more

Shandong Bailong Chuangyuan Bio-Tech Co Ltd has a Debt to Total Capital ratio of 7.73%, a higher figure than the previous year's 0.04%.
Current ratio2.66
Quick ratio2.22
Total debt/total equity0.0837
Total debt/total capital0.0773
More ▼

Growth rates in CNY

Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 97.64% and 27.98%, respectively. The positive trend in dividend payments is noteworthy since only some companies in the Food Processing industry pay a dividend. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
Div yield(5 year avg)0.37%
Div growth rate (5 year)--
Payout ratio (TTM)31.31%
EPS growth(5 years)17.23
EPS (TTM) vs
TTM 1 year ago
35.70
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.